About this Journal Submit a Manuscript Table of Contents
Journal of Allergy
Volume 2012 (2012), Article ID 969861, 2 pages
http://dx.doi.org/10.1155/2012/969861
Letter to the Editor

Comment on “Therapeutic Effects and Biomarkers in Sublingual Immunotherapy: A Review”

Allergy Associates of La Crosse, Ltd., Onalaska, WI 54650, USA

Received 4 May 2012; Accepted 29 May 2012

Copyright © 2012 George F. Kroker et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. O. Eifan, S. Keles, N. N. Bahceciler, and I. B. Barlan, “Anaphylaxis to multiple pollen allergen sublingual immunotherapy,” Allergy, vol. 62, no. 5, pp. 567–568, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. H. De Groot and A. Bijl, “Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet,” Allergy, vol. 64, no. 6, pp. 963–964, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. M. M. Cochard and P. A. Eigenmann, “Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy,” Journal of Allergy and Clinical Immunology, vol. 124, no. 2, pp. 378–379, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Blazowski, “Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose,” Allergy, vol. 63, no. 3, p. 374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. La Crosse Method; Sublingual Immunotherapy Practice Protocol, Allergychoices, La Crosse, Wis, USA, 2008.
  6. M. S. Morris, A. Lowery, D. S. Theodoropoulos, R. D. Duquette, and D. L. Morris, “Quality of life improvements with sublingual immunotherapy: a prospective study of efficacy,” Journal of Allergy, vol. 2012, Article ID 253879, 6 pages, 2012. View at Publisher · View at Google Scholar